Experts at ASN Kidney Week say earlier detection, national CKD screening, and faster uptake are needed to bring new therapies to patients.
Chee Kay Cheung, MBChB, PhD
Advertisement
Chee Kay Cheung, MBChB, PhD, is a consultant nephrologist and honorary associate professor at University Hospitals of Leicester NHS Trust.
Articles by Chee Kay Cheung, MBChB, PhD
Sparsentan cut proteinuria about 70% and kept kidney function stable over 2 years in newly diagnosed IgA nephropathy in the SPARTAN study.
Advertisement
Latest Updated Articles
Sparsentan Cuts Proteinuria 70% in New IgAN: Chee Kay Cheung, MBChBOctober 23rd 2026
Advertisement
Advertisement
Trending on AJMC
1
Real-World Cohort Ties JAK Inhibitors in Alopecia Areata to Menstrual Side Effects
2
Phase 3 Trial Tests Ensifentrine for COPD Exacerbation Prevention
3
Trends in Pharmacy Benefit Manager Market Dynamics, 2016-2025
4
Tarlatamab Plus Durvalumab Cuts Risk of Death by 58% as First-Line Maintenance in ES-SCLC
5